Author Archives: Tom Pesnot

After graduating from the ENSCR in France with a chemical engineering degree, Thomas joined KuDOS Pharma in 2005 to start his career in drug discovery. He returned to academia to undertake PhD studies on the discovery of glycosyltransferase inhibitors followed by 3 years of postdoctoral studies at University College London where he developed new biocatalytic systems to access bioactive alkaloids. In 2012, Thomas joined Redx Pharma as a medicinal chemistry project leader in oncology, immuno-oncology, and fibrosis, specializing in early-stage drug discovery. Just over three years ago, Thomas joined Concept Life Sciences, where he is now Head of Medicinal Chemistry. Thomas has authored over 30 publications, reviews, and patents in the field of synthetic chemistry, drug discovery and biocatalysis, and contributed to the discovery of several compounds now under clinical investigation.

Published 4 May 2021

Nucleosides, nucleotides & ProTide drug discovery

Join us on a journey to unleash the potential of ProTides in drug discovery, as we learn about the challenges and how to overcome them.

Tags: , , , ,

Subscribe Now